Literature DB >> 16368169

Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children.

Roos M D Bernsen1, Johan C de Jongste, Bart W Koes, Harry A Aardoom, Johannes C van der Wouden.   

Abstract

BACKGROUND: Evidence for the relationship between the diphtheria tetanus pertussis (DTP) vaccination and atopic disorders is inconclusive, because the available studies that constitute the evidence are liable to confounding by indication. STUDY
OBJECTIVE: To assess the relationship between diphtheria-tetanus-pertussis-(inactivated) poliomyelitis vaccination (DTP-IPV) in the first year of life and reported atopic disorders at primary school age.
METHOD: 1875 children attending Orthodox Reformed (Protestant) primary schools in the Netherlands returned questionnaires with data on vaccination status, atopic symptoms and lifetime atopic disorders (asthma, hay fever, eczema and food allergy), and possible confounders.
RESULTS: The adjusted odds ratio of any atopic disorder (vaccinated/unvaccinated) was 1.00 (CI95%: 0.80-1.24). For asthma, hay fever, eczema and food allergy the results were respectively: 1.04 (CI95%: 0.76-1.42), 0.79 (CI95%: 0.55-1.12), 0.87 (CI95%: 0.66-1.14) and 1.13 (CI95%: 0.71-1.81).
CONCLUSION: The DTP-IPV vaccination was not related to reported atopic disorders at primary school age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368169     DOI: 10.1016/j.vaccine.2005.10.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.

Authors:  Rob J Vandebriel; Eric R Gremmer; Michiel van Hartskamp; Jan A M A Dormans; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Vaccination safety update.

Authors:  Burkhard Schneeweiss; Michael Pfleiderer; Brigitte Keller-Stanislawski
Journal:  Dtsch Arztebl Int       Date:  2008-08-25       Impact factor: 5.594

3.  Pertussis immunization in infancy and adolescent asthma medication.

Authors:  Hartmut Vogt; Lennart Bråbäck; Anna-Maria Kling; Maria Grünewald; Lennart Nilsson
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.